Novo Nordisk A/S
NVO | NYSE
$40.00
+$0.86 (+2.20%)
At close: Oct 30, 2026, 4:00 PM ET
$39.85
-$0.15 (-0.37%)
Pre-market:
Nov 2, 2026, 8:01 AM ET
Fiscal Year Period Ending | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 | FY 2020 Dec 31, 2020 |
|---|---|---|---|---|---|---|
PE Ratio | 14.03 | 27.33 | 36.93 | 38.35 | 35.22 | 23.57 |
PEG Ratio | 8.16 | 1.28 | 0.71 | 2.14 | 2.32 | 2.37 |
PS Ratio | 4.66 | 9.50 | 13.31 | 12.03 | 11.94 | 7.82 |
PB Ratio | 7.42 | 19.23 | 29 | 25.50 | 23.77 | 95.38 |
P/FCF Ratio | 49.64 | 39.62 | 44.15 | 33.20 | 35.31 | 33.24 |
P/OCF Ratio | 12.08 | 22.81 | 28.38 | 26.99 | 30.57 | 19.11 |
OCF/S Ratio | 38.54 | 41.66 | 46.89 | 44.58 | 39.06 | 40.92 |
Debt / Equity Ratio | 0.67 | 0.72 | 0.25 | 0.31 | 0.38 | 0.16 |
Quick Ratio | 0.57 | 0.55 | 0.64 | 0.69 | 0.66 | 0.67 |
Current Ratio | 0.80 | 0.74 | 0.82 | 0.89 | 0.86 | 0.94 |
Asset Turnover | 0.57 | 0.62 | 0.74 | 0.73 | 0.72 | 5.33 |
Interest Coverage | 30.34 | 78.26 | 189.25 | 197.91 | 202.92 | 138.78 |
Return on Equity | 52.79% | 70.38% | 78.53% | 66.51% | 67.50% | 404.81% |
Return on Assets | 18.87% | 21.68% | 26.61% | 23.01% | 24.55% | 176.89% |
Return on Invested Capital | 29.53% | 38.99% | 54.20% | 49.39% | 43.62% | 318.06% |
Dividend Yield | 3.60% | 1.60% | 1.03% | 1.19% | 1.28% | 2.03% |
Payout Ratio | 50.53% | 43.71% | 37.96% | 45.57% | 45.06% | 47.75% |
FCF Payout Ratio | 178.56% | 65.52% | 46.81% | 40.42% | 46.20% | 69.27% |
Gross Profit Margin | 80.98% | 84.67% | 84.60% | 83.92% | 83.20% | 83.51% |
Net Profit Margin | 33.14% | 34.78% | 36.03% | 31.38% | 33.92% | 33.19% |
Pretax Profit Margin | 42.24% | 43.80% | 45.07% | 39.03% | 41.96% | 41.85% |
Operating Profit Margin | 41.30% | 44.19% | 44.16% | 42.28% | 41.65% | 42.64% |
FCF Margin | 9.38% | 23.99% | 30.14% | 36.24% | 33.82% | 23.53% |
EBITDA Margin | 50.71% | 50.94% | 49.35% | 43.40% | 46.44% | 46.69% |
Add to Watchlist
Select watchlists to add or remove NVO